united therapeutics glp-1 receptor agonist Understanding agonists and their impact on drug discovery A Closer Look at the

By suppressing glucagon, GLP-1 helps to lower overall blood sugar levels

Daily formulations include: Rybelsus (oral semaglutide) Saxenda (liraglutide) Victoza (liraglutide) Adlyxin (lixisenatide) Byetta (exenatide, twice daily) Weekly formulations include: Ozempic (semaglutide) Wegovy (semaglutide) Trulicity (dulaglutide) Mounjaro (tirzepatide) Zepbound (tirzepatide) Bydureon (extended-release exenatide) Longer-acting agents achieve sustained receptor activation through structural modifications such as albumin binding or Fc-fragment fusion, which extend half-life and allow once-weekly dosing

Only 10-15% rests in telogen, waiting to shed and make room for new growth

Both medications share the same gastrointestinal side effect profile, with nausea as the most common complaint

Glucagon-like peptide-1 receptor agonists improve metabolic dysfunction-associated steatotic liver disease outcomes

Calcium in the prevention of postmenopausal osteoporosis: EMAS clinical guide